Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release

BACKGROUND AND PURPOSE: Glioma is one of the most aggressive primary brain tumors and is incurable. Surgical resection, radiation, and chemotherapies have been the standard treatments for brain tumors, however, they damage healthy tissue. Therefore, there is a need for safe anticancer drug delivery...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Int J Nanomedicine
Auteurs principaux: Shahein, Samar A, Aboul-Enein, Ahmed M, Higazy, Iman M, Abou-Elella, Faten, Lojkowski, Witold, Ahmed, Esam R, Mousa, Shaker A, AbouAitah, Khaled
Format: Artigo
Langue:Inglês
Publié: Dove 2019
Sujets:
Original Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6650459/
https://ncbi.nlm.nih.gov/pubmed/31410001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S206899
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires